OBJECTIVES The aim of this work was to provide a comprehensive overview of the evolution of the health technology assessment (HTA) concept in the scientific literature through a scientometric approach. METHODS A literature search was conducted, by selecting publications, as well as news from the media, containing "health technology assessment" in their title, abstracts, or keywords. We then u...

OBJECTIVES The aim of this study was to describe the Norwegian contribution to the broad picture of our international health technology assessment (HTA) history. METHODS A general examination of some pre-HTA activities, as consensus conferences, closer reading of all background papers to the establishment of an HTA agency in Norway, the ongoing activities of this agency, its evaluation, and i...

Orphan drugs (ODs) are intended for the diagnosis, prevention, or treatment of rare diseases. Many cancer subtypes, including all childhood cancers, are defined as rare diseases, and over one-third of ODs are now intended to treat oncology indications. However, market access for oncology ODs is becoming increasingly challenging; ODs are prone to significant uncertainty around their cost-effecti...

The first steps towards Health Technology Assessment (HTA) were taken in Romania between 1992-2002 when some form of mentorship was performed in this area with Canadian support [1]; later on, from 2002 to 2011 HTA remained a subject only for the academic and research purposes. Only the pressure brought by the Memorandum of Understanding between Romanian Government with International Monetary Fu...

This research was conducted to organize and model a comprehensive paratransit dispatching task activity in a computer-assisted control room. The dispatching task involves continuous monitoring and interaction with archived and real-time data using a dispatch software. Extensive field observations and video recordings of dispatch operations were conducted. Then, an expert dispatcher was used to ...

One of the main purposes of conducting a health technology assessment (HTA) is to provide decision makers, patients, related researchers (e.g., in the areas of health policy, HTA, or health technology development), and reimbursement payers with information about the economic, organizational, social, and ethical impacts of specific health technologies, as well as obtaining clinical evidence and ...

Also, a fully searchable CD-ROM containing the full text of all HTA monographs is available from the NCCHTA offices or via the HTA website. The CD-ROM is updated with the most recently published monographs every 6 months and is available free of charge to postal addresses in the UK. In addition, printed paper copies of this report may be obtained by writing to: The website also provides informa...

Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph. You can order HTA monographs from our Despatch Agents: – fax (with credit ca...

The objective of this Health Technology Assessment (HTA) methods report was to examine and to assess decision analysis (DA) as a method to transfer and adapt international scientific evidence in HTA to the German health care context. Furthermore, we sought to develop a systematic framework to facilitate the selection, transfer, adaptation, and synthesis of these data in German HTA projects.In t...

OBJECTIVES Although there is increased awareness of patient and public involvement (PPI) among health technology assessment (HTA) organizations, evaluations of PPI initiatives are relatively scarce. Our objective as members of Health Technology Assessment International's (HTAi's) Patient and Citizen Involvement Group (PCIG) was to advance understanding of the range of evaluation strategies adop...